DRUGS

DRUGS(英文缩写 DRUGS),ISSN 0012-6667,eISSN 1179-1950 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

指标来源：jcr_cas_ifqb

历年影响因子趋势

DRUGS 最新收录文献

※ 中文译文由 AI 辅助生成,仅供学术参考,请以英文原文为准。

1. Sugammadex: a review of its use in anaesthetic practice.
   Lily P H Yang, Susan J Keam
   Drugs 2009 IF: 14.70 Q1 PMID: 19441874

   Sugammadex (Bridion), a modified gamma-cyclodextrin, is the first selective relaxant binding agent indicated to reverse the neuromuscular blockade induced during general anaesthesia to facilitate surg…

   查看详情 DOI
2. Exemestane: a review of its use in postmenopausal women with breast cancer.
   Emma D Deeks, Lesley J Scott
   Drugs 2009 IF: 14.70 Q1 PMID: 19441873

   Exemestane (Aromasin) is an orally active steroidal irreversible inactivator of the aromatase enzyme indicated as an adjuvant treatment in postmenopausal women with estrogen receptor-positive early-st…

   查看详情 DOI
3. Bortezomib: a review of its use in patients with multiple myeloma.
   Monique P Curran, Kate McKeage
   Drugs 2009 IF: 14.70 Q1 PMID: 19441872

   Bortezomib (VELCADE) is a proteasome inhibitor that not only targets the myeloma cell, but also acts in the bone marrow micro-environment, inhibiting the binding of myeloma cells to bone marrow stroma…

   查看详情 DOI
4. Emtricitabine/tenofovir disoproxil fumarate: in combination with a protease inhibitor in HIV-1 infection.
   Caroline M Perry
   Drugs 2009 IF: 14.70 Q1 PMID: 19441871

   Emtricitabine, a nucleoside reverse transcriptase inhibitor (RTI), and tenofovir disoproxil fumarate (tenofovir DF), a nucleotide RTI, as a fixed-dose combination tablet (emtricitabine/tenofovir DF) f…

   查看详情 DOI
5. Aliskiren/hydrochlorothiazide combination: in mild to moderate hypertension.
   Claudine M Baldwin, Greg L Plosker
   Drugs 2009 IF: 14.70 Q1 PMID: 19441870

   Aliskiren/hydrochlorothiazide is a single-pill combination of the first in the new class of non-peptide direct renin inhibitors (aliskiren) and a thiazide diuretic (hydrochlorothiazide [HCTZ]) that ac…

   查看详情 DOI
6. Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus.
   George G Zhanel, Grace Sniezek, Frank Schweizer, Sheryl Zelenitsky, Philippe R S Lagacé-Wiens, Ethan Rubinstein
   Drugs 2009 IF: 14.70 Q1 PMID: 19441869

   Ceftaroline is a broad-spectrum cephalosporin currently under clinical investigation for the treatment of complicated skin and skin-structure infections (cSSSI), including those caused by meticillin-r…

   查看详情 DOI
7. Cranberry and urinary tract infections.
   David R P Guay
   Drugs 2009 IF: 14.70 Q1 PMID: 19441868

   Urinary tract infection (UTI) refers to the presence of clinical signs and symptoms arising from the genitourinary tract plus the presence of one or more micro-organisms in the urine exceeding a thres…

   查看详情 DOI
8. Novel approaches for pharmacological management of atrial fibrillation.
   Joachim R Ehrlich, Stanley Nattel
   Drugs 2009 IF: 14.70 Q1 PMID: 19441867

   In the light of the progressively increasing prevalence of atrial fibrillation (AF), medical awareness of the need to develop improved therapeutic approaches for the arrhythmia has also risen over the…

   查看详情 DOI
9. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. 铁羧麦芽糖：其在缺铁性贫血中的应用综述
   Katherine A Lyseng-Williamson, Gillian M Keating
   Drugs 2009 IF: 14.70 Q1 PMID: 19405553

   Ferric carboxymaltose (Ferinject(R)), a novel iron complex that consists of a ferric hydroxide core stabilized by a carbohydrate shell, allows for controlled delivery of iron to target tissues. Admini…

   查看详情 DOI
10. Fesoterodine.
    Kate McKeage, Gillian M Keating
    Drugs 2009 IF: 14.70 Q1 PMID: 19405552

    black triangle Fesoterodine is a muscarinic receptor antagonist that is rapidly and extensively converted to the active and more potent metabolite 5-hydroxymethyltolterodine. The drug is approved for …

    查看详情 DOI